Pricing Log in Create free account

Haleon PLC Sponsored ADR (HLN) vs United Therapeutics Corporation (UTHR)

Haleon PLC Sponsored ADR and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. Haleon PLC Sponsored ADR is the larger, with a market value of $40.2B against $24.3B — 1.7× the size. United Therapeutics Corporation trades at the lower P/E: 19.7× against 20.5×. United Therapeutics Corporation has the higher net margin (38.6% vs 11.2%) and the higher return on invested capital (30.1% vs 0.00%). Across the 21 metrics below, United Therapeutics Corporation leads on 14 and Haleon PLC Sponsored ADR on 7.

Valuation

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
P/E 20.48 19.75 20.55
P/S 2.32 7.57 2.08
P/B 1.90 3.77 1.79
Price to free cash flow 9.23 27.99 16.29
EV/EBITDA 12.22 14.74 12.22
EV/Sales 2.87 6.55 2.87
Earnings yield 4.88% 5.06% (15.94%)
Free cash flow yield 10.84% 3.57% 0.00%

Profitability

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 86.34% 53.51%
Operating margin 17.93% 41.45% 0.00%
Net margin 11.18% 38.61% (2.45%)
Free cash flow margin 0.00% 27.21% 0.00%
Return on equity 0.00% 19.13% (0.80%)
Return on assets 0.00% 17.11% (1.67%)
Return on invested capital 0.00% 30.13% 0.00%

Growth

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 1.89% 5.22%
EPS growth (last fiscal year) 22.50% 13.07% 42.91%
Revenue growth, 5-year CAGR 1.43% 16.50% 7.24%
Net income growth, 5-year CAGR 6.98% 20.99% 0.00%

Health

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.04
Current ratio 0.69 4.66 2.41
Net debt to EBITDA 2.63 (1.85) 1.01

Dividend

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Dividend yield 2.16% — 1.45%
Payout ratio — — 0.27

Size

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Market cap 40.24b 24.26b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack